Efalizumab, a human monoclonal anti-CD11a antibody, in the treatment of moderate to severe Crohn's Disease: an open-label pilot study (Q82955028)
Jump to navigation
Jump to search
scientific article published on 19 December 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Efalizumab, a human monoclonal anti-CD11a antibody, in the treatment of moderate to severe Crohn's Disease: an open-label pilot study |
scientific article published on 19 December 2010 |
Statements
Efalizumab, a human monoclonal anti-CD11a antibody, in the treatment of moderate to severe Crohn's Disease: an open-label pilot study (English)
Dustin G James
Da Hea Seo
Jiajing Chen
Caroline Vemulapalli
Christian D Stone
19 December 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference